help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friesema, E. C. H.
Right arrow Articles by Visser, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friesema, E. C. H.
Right arrow Articles by Visser, T. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LEVOTHYROXINE
*LIOTHYRONINE
Endocrinology Vol. 139, No. 2 596-600
Copyright © 1998 by The Endocrine Society

ARTICLES

Rapid Sulfation of 3,3',5'-Triiodothyronine in Native Xenopus laevis Oocytes

Edith C. H. Friesema, Roelof Docter, Eric P. Krenning, Maria E. Everts1, Georg Hennemann and Theo J. Visser

Departments of Internal Medicine III (E.C.H.F., R.D., E.P.K., M.E.E., G.H., T.J.V.) and Nuclear Medicine (E.P.K.), Erasmus University Medical School, Rotterdam, The Netherlands

Address all correspondence and requests for reprints to: Dr. Theo J. Visser, Department of Internal Medicine III, Room Bd234, Erasmus University Medical School, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. E-mail: visser{at}inw3.azr.nl


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Sulfation is an important metabolic pathway facilitating the degradation of thyroid hormone by the type I iodothyronine deiodinase. Different human and rat tissues contain cytoplasmic sulfotransferases that show a substrate preference for 3,3'-diiodothyronine (3,3'-T2) > T3 > rT3 > T4. During investigation of the expression of plasma membrane transporters for thyroid hormone by injection of rat liver RNA in Xenopus laevis oocytes, we found uptake and metabolism of iodothyronines by native oocytes. Groups of 10 oocytes were incubated for 20 h at 18 C in 0.1 ml medium containing 500,000 cpm (1–5 nM) [125I]T4, [125I]T3, [125I]rT3, or [125I]3,3'-T2. In addition, cytosol prepared from oocytes was tested for iodothyronine sulfotransferase activity by incubation of 1 mg cytosolic protein/ml for 30 min at 21 C with 1 µM [125I]T4, [125I]T3, [125I]rT3, or [125I]3,3'-T2 and 50 µM 3'-phosphoadenosine-5'-phosphosulfate. Incubation media, oocyte extracts, and assay mixtures were analyzed by Sephadex LH-20 chromatography for production of conjugates and iodide. After 20-h incubation, the percentage of added radioactivity present as conjugates in the media and oocytes amounted to 0.9 ± 0.2 and 1.0 ± 0.1 for T4, less than 0.1 and less than 0.1 for T3, 32.5 ± 0.4 and 29.3 ± 0.2 for rT3, and 3.8 ± 0.3 and 2.3 ± 0.2 for 3,3'-T2, respectively (mean ± SEM; n = 3). The conjugate produced from rT3 was identified as rT3 sulfate, as it was hydrolyzed by acid treatment. After injection of oocytes with copy RNA coding for rat type I iodothyronine deiodinase, we found an increase in iodide production from rT3 from 2.3% (water-injected oocytes) to 46.2% accompanied by a reciprocal decrease in rT3 sulfate accumulation from 53.7% to 7.1%. After 30-min incubation with cytosol and 3'-phosphoadenosine-5'-phosphosulfate, sulfate formation amounted to 1.8% for T4, less than 0.1% for T3, 77.9% for rT3, and 2.9% for 3,3'-T2. These results show that rT3 is rapidly metabolized in native oocytes by sulfation. The substrate preference of the sulfotransferase activity in oocytes is rT3 >> 3,3'-T2 > T4 > T3. The physiological significance of the high activity for rT3 sulfation in X. laevis oocytes remains to be established.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
THE MAIN secretory product of the thyroid gland, T4, is enzymatically converted in peripheral tissues to the biologically active hormone T3 (1). This transformation concerns the elimination of an iodine from the phenolic ring of T4, also termed outer ring deiodination (ORD). Deiodination of the tyrosyl ring [inner ring deiodination (IRD)] is an inactivation step by which T4 and T3 are converted to the inactive metabolites rT3 and 3,3'-diiodothyronine (3,3'-T2), respectively. The latter is also produced by ORD of rT3 (2). These reactions are catalyzed by different iodothyronine deiodinases with distinct tissue distributions. The type I iodothyronine deiodinase (D1) is found predominantly in liver, kidney, and thyroid. It is a nonselective enzyme capable of ORD as well as IRD of different iodothyronines (1, 2, 3).

Besides deiodination, conjugation of the phenolic hydroxyl group with glucuronic acid or sulfate is another important step in thyroid hormone metabolism (2). In general, the purpose of these so-called phase II detoxification reactions is to increase the water solubility of lipophilic substances and, thus, to facilitate their excretion in bile and/or urine (4). The iodothyronine glucuronides are stable conjugates that are rapidly excreted in the bile (2). However, sulfate conjugation has been shown to facilitate the subsequent deiodination of iodothyronines by D1 in the liver (5, 6). Although sulfation blocks the ORD of T4, it strongly facilitates the IRD of both T4 and T3, suggesting that sulfation is an important step in the irreversible inactivation of thyroid hormone (5, 6).

Sulfate conjugation of various compounds is catalyzed by sulfotransferases, which represent a group of homologous enzymes with overlapping substrate specificities that occur in the cytosolic fraction of different tissues, in particular liver (7). For all these enzymes 3'-phosphoadenosine-5'-phosphosulfate (PAPS) acts as the sulfate donor. Iodothyronine sulfotransferase activities in rat and human tissues show a substrate preference for 3,3'-T2 >> T3 > rT3 > T4 (8, 9, 10, 11, 12).

In experiments to express plasma membrane transport proteins for thyroid hormone by injection of RNA from rat tissues in Xenopus laevis oocytes (13), we found that native oocytes transport and sulfate iodothyronines, in particular rT3. We have, therefore, investigated the uptake and metabolism of T4, T3, rT3, and 3,3'-T2 by X. laevis oocytes as well as the sulfation of these compounds by isolated oocyte cytosol.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Materials
T4, T3, PAPS, and dithiothreitol were obtained from Sigma Chemical Co. (St. Louis, MO). rT3, 3,3'-T2, and 3-iodothyronine (3-T1) were obtained from Henning Berlin (Berlin, Germany). [3',5'-125I]T4 [43 megabecquerels (MBq)/nmol], [3'-125I]T3 (>66 MBq/nmol), and carrier-free Na125I (80 MBq/nmol) were purchased from Amersham (Aylesbury, UK). [3',5'-125I]rT3 and 3,[3'-125I]T2 were prepared from Na125I and 3,3'-T2 or 3-T1, respectively, using the chloramine-T method, followed by purification on Sephadex LH-20 (12). Sephadex LH-20 was obtained from Pharmacia (Uppsala, Sweden). All other chemicals were of reagent grade.

Capped rat D1 copy RNA (cRNA) was prepared from the complementary DNA in pBluescript (14) (provided by Dr. P. Reed Larsen), linearized with XhoI (Boehringer Mannheim, Mannheim, Germany), using the AmpliScribe T3 transcription kit (Epicentre Technologies, Madison, WI) according to the protocol of the supplier. For capping, the m7G[5']ppp[5']G cap analog was used. cRNA pellets were dissolved in water (0.04 µg/µl) and stored at -80 C.

Animals
Two- to 3-yr-old adult X. laevis females were obtained from the Hubrecht Laboratory (Utrecht, The Netherlands). Frogs were maintained in a water-filled tank with three dark sides at a temperature of 18–22 C. A 12-h light, 12-h dark cycle was maintained to reduce seasonal variations in oocyte quality. Frogs were fed twice a week, and water was changed immediately after feeding.

Oocyte isolation and RNA injection
Oocytes were prepared as described previously (13). After isolation, the oocytes were sorted manually on morphological criteria, such as size, polarization, pigmentation, and absence of follicular layer debris. Healthy-looking stage V–VI oocytes (15) were transferred to six-well tissue culture plates and incubated in the dark at 18 C in modified Barth’s solution [88 mM NaCl, 1 mM KCl, 0.82 mM MgSO4, 0.4 mM CaCl2, 0.33 mM Ca(NO3)2, 2.4 mM NaHCO3, and 10 mM HEPES (pH 7.4), containing 10 IU/ml penicillin and 10 µg/ml streptomycin]. The next day, oocytes were injected with 23 nl water containing 0.92 ng D1 cRNA using the Nanoject system (Drummond Scientific, Broomall, PA). Injected and uninjected oocytes were maintained for 3–4 days at 18 C in modified Barth’s solution, with daily change of medium.

Uptake and metabolism assays
Groups of 10 oocytes were transferred to a 96-well tissue culture plate and subsequently incubated in the dark at 18 C with 4 nM [125I]T4, 5 nM [125I]T3, 2 nM [125I]rT3, or 2 nM [125I]T2 in 0.1 ml sodium-containing incubation medium (100 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, and 10 mM Tris, pH 7.5). After 20 h, incubation medium was collected, and the oocytes were transferred to tubes and washed four times with 2.5 ml ice-cold sodium buffer containing 0.1% BSA. Two groups of 5 oocytes from each group of 10 were transferred to new tubes, counted, and lysed with 0.1 ml 0.1 M NaOH. Lysates were cleared by centrifugation. Lysates (in duplicate) and incubation media were acidified with 0.1 M HCl and analyzed by Sephadex LH-20 chromatography (16). The products were separated by successive elutions with 1 ml 0.1 M HCl (iodide) twice, 1 ml water (conjugates) 6 times, and 1 ml 1% NH4OH in ethanol (iodothyronines) three times.

rT3 conjugate hydrolysis
Acid hydrolysis of rT3 conjugate was tested by incubation for 1 h at 80 C in 1 M HCl (17). The reaction was stopped by placing the mixtures on ice, and the products were analyzed by Sephadex LH-20 chromatography as described above.

Sulfotransferase assay
Oocytes were homogenized on ice in 2–3 vol 0.1 M phosphate buffer (pH 7.2), 2 mM EDTA, and 1 mM dithiothreitol, and cytosol was isolated after centrifugation for 1 h at 100,000 x g. The protein concentration was determined by the method of Bradford (18), using BSA as the standard.

Iodothyronine sulfotransferase activities were measured by incubation of 1 µM T4, T3, rT3, or 3,3'-T2 and 100,000 cpm of the 125I-labeled compound for 30 min at 37 C (optimal temperature for warm-blooded animals) or 21 C (optimal temperature for cold-blooded animals) with 0.1 or 1 mg cytosolic protein/ml in the presence (in triplicate) or absence (blank) of 50 µM PAPS in 0.2 ml 0.1 M phosphate buffer (pH 7.2) and 2 mM EDTA, as described previously (11, 12). The reaction was started by the addition of diluted cytosol and was stopped by the addition of 0.8 ml 0.1 M HCl. Iodothyronine sulfate formation was analyzed by Sephadex LH-20 chromatography as described above.

Statistics
Uptake and metabolism studies were performed with groups of 10 oocytes. Data are expressed as the percent uptake of total radioactivity per 10 oocytes and are presented as the mean ± SEM. Statistical significance was evaluated by Student’s t test for unpaired observations.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Uptake and metabolism of iodothyronines in oocytes
The percentage of added radioactivity present in the media and, after washing, in the oocytes after 20-h incubation amounted to 19.4 ± 3.7 and 67.1 ± 7.0 for T4, 3.3 ± 0.3 and 51.5 ± 0.7 for T3, 50.9 ± 1.4 and 35.0 ± 1.4 for rT3, and 24.2 ± 0.5 and 68.1 ± 0.7 for 3,3'-T2 (Fig. 1Go). The incomplete recovery of radioactivity, in particular with [125I]T3, is primarily due to adsorption of label to the tube as the incubation medium did not contain protein. For T4, T3, and 3,3'-T2, almost all radioactivity present in the oocytes was in the form of the added iodothyronine. However, only 15.4 ± 0.5% and 4.9 ± 0.1% of the added [125I]rT3 was recovered as intact iodothyronine from the medium and oocytes, respectively. After incubation with [125I]rT3, most of the added radioactivity was recovered as conjugate, i.e. 32.3 ± 0.4% in the medium and 29.3 ± 0.2% in the oocytes, indicating active conjugation of rT3 in the oocytes. With none of the iodothyronines was significant iodide production observed in the oocytes.



View larger version (40K):
[in this window]
[in a new window]
  		Figure 1. Uptake and metabolism of [125I]T4 (A), [125I]T3 (B), [125I]rT3 (C), and [125I]3,3'-T2 (D) during incubation for 20 h at 18 C with 10 oocytes. Percentages of iodide ({blacksquare}), conjugates (), and iodothyronines () in the incubation buffer and in the homogenized oocytes, analyzed by Sephadex LH-20 chromatography. Bars represent the mean ± SEM (n = 3).

 
Native iodothyronines are regenerated from their sulfate conjugates by acid-catalyzed hydrolysis (17). The conjugate formed after incubation of rT3 with oocytes was completely hydrolyzed after treatment for 1 h at 80 C with 1 M HCl (Fig. 2Go), indicating that rT3 was indeed sulfated by the oocytes.



View larger version (37K):
[in this window]
[in a new window]
  		Figure 2. Acid-catalyzed hydrolysis of rT3 conjugate produced after incubation of [125I]rT3 for 20 h at 18 C with 10 oocytes. The percentages of iodide ({blacksquare}), conjugate (), and rT3 () in the incubation medium and oocytes before and after the acid-catalyzed hydrolysis were determined by Sephadex LH-20 chromatography. Results are derived from a duplicate incubation in a representative experiment.

 
Injection of cRNA coding for rat D1 resulted, after incubation of the oocytes for 20 h with [125I]rT3, in a large increase in iodide formation from 2.3% to 46.2% of the added radioactivity, which was accompanied by a reciprocal decrease in rT3 sulfate (rT3S) accumulation from 53.7% to 7.1% compared with that in water-injected oocytes (Fig. 3Go). Water-injected oocytes showed the same rate of rT3 sulfation as native (uninjected) oocytes (Figs. 1CGo and 3Go). Figure 3Go also shows that the amount of iodide in the D1 cRNA-injected oocytes incubated with [125I]rT3 was 3 times higher than that in the medium.



View larger version (31K):
[in this window]
[in a new window]
  		Figure 3. Metabolism of rT3 in D1 cRNA-injected and water-injected oocytes during incubation of [125I]rT3 for 20 h at 18 C with 10 oocytes. Percentages of iodide ({blacksquare}), conjugates (), and rT3 () in the incubation medium and oocytes were determined by Sephadex LH-20 chromatography. Bars represent the mean ± SEM (n = 3).

 
Sulfotransferase assay
Iodothyronine sulfotransferase activities were measured in cytosol from native oocytes at incubation temperatures of 37 and 21 C, producing the same results (not shown). Figure 4Go presents the results of the experiments performed at 21 C. Although sulfation rates were higher at 1 than at 0.1 mg cytosolic protein/ml, the pattern of sulfation of the different iodothyronines was independent of the protein concentration. The sulfotransferase activity in oocyte cytosol showed a preference for rT3 >> 3,3'-T2 > T4 > T3.



View larger version (18K):
[in this window]
[in a new window]
  		Figure 4. Sulfation of 1 µM iodothyronines during incubation for 30 min at 21 C with oocyte cytosol in the presence of 50 µM PAPS. The cytosolic protein concentration amounted to 0.1 mg/ml ({blacksquare}) and 1.0 mg/ml (). Results are the means of two closely agreeing experiments.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
In experiments using X. laevis oocytes to express rat liver cell membrane transporters for thyroid hormones (13), we found that native X. laevis oocytes transport iodothyronines and sulfate rT3. We also found that transport and sulfation of rT3 in oocytes injected with rat liver messenger RNA (mRNA) were similar to those in uninjected oocytes (data not shown). Thus, the possible induction of an exogenous transport protein for rT3 by the injection of rat liver mRNA was completely masked by the endogenous transport system for rT3 in the oocytes. This is in contrast to previous findings concerning the expression of hepatic cell membrane transporters for T3 and T4 (13), showing that injection of rat liver mRNA or partially purified fractions thereof induces a significant 2- to 3-fold increase in T3 and T4 transport into oocytes.

After 20-h incubation with 125I-labeled T4, T3, or 3,3'-T2, most radioactivity was associated with the oocytes as unmetabolized iodothyronines. As after incubation the oocytes were extensively washed in BSA-containing medium, cell-associated radioactivity most likely represents internalized iodothyronine. This conclusion is supported by the observation that uptake of iodothyronines by X. laevis oocytes is a Na+-dependent process (13). On the contrary, after 20-h incubation with [125I]rT3, most radioactivity was recovered from the medium, largely as rT3S. Taking medium and oocytes together, more than 50% of added rT3 was sulfated. Sulfation of iodothyronines is catalyzed by cytoplasmic sulfotransferases (7, 8, 9, 10, 11, 12), which enzymes are apparently also present in oocytes. These results, therefore, support the conclusion that rT3 was internalized by the oocytes and sulfated intracellularly. Subsequently, (part of) the rT3S formed is transported back to the medium. The finding that after 20-h incubation of oocytes with rT3 and other iodothyronines almost no iodide is formed indicates that X. laevis oocytes possess little or no endogenous D1 activity, in agreement with the findings of St. Germain et al. (19). In fact, D1 activity is not expressed at any stage of development in amphibians (20). On the other hand, injection of cRNA coding for rat D1 leads to a large increase in iodide production from rT3 at the expense of rT3S accumulation. As, like native D1 in mammalian cells, exogenous D1 in oocytes is probably located intracellularly (1, 2, 3), these results again strongly support the presence of an endogenous transporter(s) for iodothyronines in X. laevis oocytes.

D1 is a nonselective enzyme capable of both ORD and IRD of iodothyronines (1, 2, 3). The enzyme is most effective in the ORD of rT3, but the deiodination of different iodothyronines is dramatically affected by the sulfation of these compounds (5, 6). Thus, IRD of both T4 and T3 by rat D1 is accelerated 40–200 times after their sulfation, suggesting that sulfation is an important step, leading to the irreversible inactivation of thyroid hormone (5, 6). In contrast, ORD of T4 is completely blocked by sulfation. This is not a general phenomenon, as ORD of rT3 by rat D1 is not affected by sulfation of this substrate, whereas ORD of 3,3'-T2 is facilitated 50-fold by sulfation (5, 6). In contrast to the facilitated deiodination of iodothyronine sulfates by D1, deiodination of iodothyronines by the type II (D2) and type III (D3) iodothyronine deiodinases is inhibited by sulfation (21) (Visser, T. J., unpublished observations). As rT3 and rT3S are deiodinated equally well by rat D1, it is uncertain to what extent iodide production from rT3 in rat D1 cRNA-injected oocytes proceeds via rT3S or represents direct ORD of rT3. The iodide formed remains trapped inside the oocytes, indicating the absence of transporters for both influx and efflux of iodide in native oocytes, in accordance with the studies of Dai et al. (22).

Our experiments have not directly addressed the possible IRD of the different iodothyronines in the oocytes. However, St. Germain et al. (23) have shown that native X. laevis oocytes kept in Barth’s medium do not express D3. Moreover, we did not find conjugate formation after incubation of T4 with oocytes, which would have been expected if T4 underwent IRD to rT3. Therefore, it is also unlikely that T3 was metabolized by IRD in the oocytes.

Sulfate conjugation of iodothyronines is catalyzed by phenol sulfotransferases located in the cytosolic fraction of different tissues (7). In both rats and humans, iodothyronine sulfotransferase activities show a substrate preference for 3,3'-T2 >> T3 > rT3 > T4, with rT3 being a relatively poor substrate (8, 9, 10, 11, 12). Our results show that sulfotransferase activity in X. laevis oocyte cytosol has a clear substrate preference for rT3, whereas 3,3'-T2, T3, and T4 are hardly sulfated at all. The physiological importance of thyroid hormone sulfation is still unknown. As discussed above, sulfation is an irreversible pathway of thyroid hormone metabolism when D1 activity is high, as sulfated iodothyronines are rapidly degraded by this enzyme (5, 6). However, sulfation is a reversible pathway of thyroid hormone inactivation when D1 activity is low because of the regeneration of free iodothyronines by sulfatases produced in different tissues and by intestinal bacteria (5, 6). It has been speculated that due to the low D1 activity during fetal development in mammals, sulfation/desulfation of T3 is an important mechanism for the tissue-specific and time-dependent regulation of thyroid hormone bioactivity (6, 21). Indeed, high concentrations not only of T3S, but also of T4S, rT3S, and 3,3'-T2S have been detected in fetal sheep serum and human cord serum (24, 25).

It is remarkable that during embryonic and fetal development in different organisms, two active pathways exist for the inactivation of thyroid hormone: IRD of T4 to rT3 and of T3 to 3,3'-T2 by D3, and sulfation (1, 2, 3, 24, 25). That these are true inactivation pathways is suggested by the findings that rT3, 3,3'-T2, and T3S have little or no affinity for the T3 receptor (26, 27). Thyroid hormone plays an important role not only in the embryonic development of tadpoles, but also in the metamorphosis of the tadpole to the froglet (20). This requires the tissue-specific and development stage-dependent regulation of the balance between thyroid hormone activation by D2 and inactivation by D3 (20). We hypothesize that sulfation/desulfation contributes to the regulation of thyroid hormone bioactivity during embryonic development and metamorphosis in frogs. Although direct evidence is lacking, this hypothesis is supported by the absence of D1 in frogs (20). Why, then, the sulfotransferase(s) involved shows a profound substrate preference for rT3 remains unknown. The possibility that rT3S exerts a biological function by binding to a transcription factor other than the T3 receptor deserves investigation.


   Acknowledgments
 
We thank Prof. P. Reed Larsen, Brigham and Womens Hospital, Harvard Medical School (Boston, MA) for his generous gift of D1 complementary DNA. Furthermore, we are grateful to Ms. E. P. C. M. Moerings and Ms. E. Kaptein for their effort in helping with the experiments.


   Footnotes
 
1 Recipient of a fellowship from the Royal Netherlands Academy of Arts and Sciences. Present address: Department of Physiology, University of Utrecht School of Veterinary Medicine, Utrecht, The Netherlands. Back

Received June 9, 1997.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Larsen PR, Berry MJ 1995 Nuritional and hormonal regulation of iodothyronine metabolism. Annu Rev Nutr 15:323–352[CrossRef][Medline]
  2. Leonard JL, Köhrle J 1996 Intracellular pathways of iodothyronine metabolism. In: Braverman LE, Utiger RD (eds) The Thyroid. Lippincott-Raven, Philadelphia, pp 144–189
  3. Visser TJ 1996 Pathways of thyroid hormone metabolism. Acta Med Austriaca 23:10–16[Medline]
  4. Klaassen CD, Watkins JB 1984 Mechanisms of bile formation, hepatic uptake and biliary excretion. Pharmacol Rev 36:1–67[Medline]
  5. Visser TJ, van Buuren JCJ, Rutgers M, Eelkman Rooda SJ, de Herder WW 1990 The role of sulfation in thyroid hormone metabolism. Trends Endocrinol Metab 1:211–218
  6. Visser TJ 1994 Role of sulfation in thyroid hormone metabolism. Chem Biol Interact 92:293–303[CrossRef][Medline]
  7. Yamazoe Y, Nagata K, Ozawa S, Kato R 1994 Structural similarity and diversity of sulfotransferases. Chem Biol Interact 92:107–117[CrossRef][Medline]
  8. Sekura RD, Sato K, Cahnmann HJ, Robbins J, Jakoby WB 1981 Sulfate transfer to thyroid hormones and their analogs by hepatic aryl sulfotransferases. Endocrinology 108:454–456[Abstract/Free Full Text]
  9. Young WF, Gorman CA, Weinshilboum RM 1988 Triiodothyronine: a substrate for the thermostable and thermolabile forms of human phenol sulfotransferases. Endocrinology 122:1816–1824[Abstract/Free Full Text]
  10. Gong DW, Murayama N, Yamazoe Y, Kato R 1992 Hepatic triiodothyronine sulfation and its regulation by growth hormone and triiodothyronine in rats. J Biochem (Tokyo) 112:112–116[Abstract/Free Full Text]
  11. Visser TJ, Kaptein E, Glatt H, Bartsch I, Hagen M, Coughtrie MWH Characterization of thyroid hormone sulfotransferases. Chem Biol Interact, in press
  12. Kaptein E, van Haasteren GAC, Linkels E, de Greef WJ, Visser TJ 1997 Characterization of iodothyronine sulfotransferase activity in rat liver. Endocrinology 138:5136–5143[Abstract/Free Full Text]
  13. Docter R, Friesema ECH, van Stralen PGJ, Krenning EP, Everts ME, Visser TJ, Hennemann G 1997 Expression of rat liver cell membrane transporters for thyroid hormone in Xenopus laevis oocytes. Endocrinology 138:1841–1846[Abstract/Free Full Text]
  14. Berry MJ, Banu L, Larsen PR 1991 Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 349:438–440[CrossRef][Medline]
  15. Dumont JA 1972 Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals. J Morphol 136:153–180[CrossRef][Medline]
  16. Docter R, Krenning EP, Bernard HF, Visser TJ, Hennemann G 1988 Inhibition of uptake of thyroid hormone into rat hepatocytes by preincubation with N-bromoacetyl-3,3',5-triiodothyronine. Endocrinology 123:1520–1525[Abstract/Free Full Text]
  17. Mol JA, Visser TJ 1985 Synthesis and some properties of sulfate esters and sulfamates of iodothyronines. Endocrinology 117:1–7[Abstract/Free Full Text]
  18. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254[CrossRef][Medline]
  19. St. Germain DL, Morganelli CM 1989 Expression of type I iodothyronine 5'-deiodinase in Xenopus laevis oocytes. J Biol Chem 264:3054–3056[Abstract/Free Full Text]
  20. Galton VA 1992 The role of thyroid hormone in amphibian metamorphosis. Trends Endocrinol Metab 3:96–100[CrossRef][Medline]
  21. Santini F, Hurd RE, Chopra IJ 1992 A study of metabolism of deaminated and sulfoconjugated iodothyronines by rat placental iodothyronine 5-monodeiodinase. Endocrinology 131:1689–1694[Abstract/Free Full Text]
  22. Dai G, Levy O, Carrasco N 1996 Cloning and characterisation of the thyroid iodide transporter. Nature 379:458–460[CrossRef][Medline]
  23. St Germain DL, Schwartzman RA, Croteau W, Kanamori A, Wang Z, Brown DD, Galton VA 1994 A thyroid hormone-regulated gene in Xenopus laevis encodes a type III iodothyronine 5-deiodinase. Proc Natl Acad Sci USA 91:7767–7771[Abstract/Free Full Text]
  24. Chopra IJ, Santini F, Wu SY, Hurd RE 1994 The role of sulfation and desulfation in thyroid hormone metabolism. In: Wu SY, Visser TJ (eds) Thyroid Hormone Metabolism: Molecular Biology and Alternate Pathways. CRC Press, Boca Raton, pp 119–138
  25. Polk D, Wu SY, Fisher DA 1994 Alternate pathways of thyroid hormone metabolism in developing mammals. In: Wu SY, Visser TJ (eds) Thyroid Hormone Metabolism: Molecular Biology and Alternate Pathways. CRC Press, Boca Raton, pp 223–243
  26. Oppenheimer JH, Schwartz HL, Strait KA 1996 The molecular basis of thyroid hormone actions. In: Braverman LE, Utiger RD (eds) The Thyroid. Lippincott-Raven, Philadelphia, pp 162–184
  27. Spaulding SW 1994 Bioactivities of conjugated iodothyronines. In: Wu SY, Visser TJ (eds) Thyroid Hormone Metabolism: Molecular Biology and Alternate Pathways. CRC Press, Boca Raton, pp 139–153



This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
E. C. H. Friesema, S. Ganguly, A. Abdalla, J. E. M. Fox, A. P. Halestrap, and T. J. Visser
Identification of Monocarboxylate Transporter 8 as a Specific Thyroid Hormone Transporter
J. Biol. Chem., October 10, 2003; 278(41): 40128 - 40135.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. H. A. G. M. van der Putten, E. C. H. Friesema, N. A. Abumrad, M. E. Everts, and T. J. Visser
Thyroid Hormone Transport by the Rat Fatty Acid Translocase
Endocrinology, April 1, 2003; 144(4): 1315 - 1323.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. P. Peeters, E. C. H. Friesema, R. Docter, G. Hennemann, and T. J. Visser
Effects of thyroid state on the expression of hepatic thyroid hormone transporters in rats
Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1232 - E1238.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. C. H. Friesema, R. Docter, E. P. C. M. Moerings, F. Verrey, E. P. Krenning, G. Hennemann, and T. J. Visser
Thyroid Hormone Transport by the Heterodimeric Human System L Amino Acid Transporter
Endocrinology, October 1, 2001; 142(10): 4339 - 4348.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
G. Hennemann, R. Docter, E. C. H. Friesema, M. de Jong, E. P. Krenning, and T. J. Visser
Plasma Membrane Transport of Thyroid Hormones and Its Role in Thyroid Hormone Metabolism and Bioavailability
Endocr. Rev., August 1, 2001; 22(4): 451 - 476.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friesema, E. C. H.
Right arrow Articles by Visser, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friesema, E. C. H.
Right arrow Articles by Visser, T. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LEVOTHYROXINE
*LIOTHYRONINE

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals